Skip to main content

REVIEW article

Front. Immunol.

Sec. Vaccines and Molecular Therapeutics

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1524317

Technological Breakthroughs and Advancements in the Application of mRNA Vaccines: A Comprehensive Exploration and Future Prospects

Provisionally accepted
  • 1 School of Basic Medical Sciences, Inner Mongolia University for Nationalities, Tongliao, China
  • 2 Keerqin District First People’s Hospital, Tongliao, China
  • 3 Brucellosis Prevention and Treatment Engineering Research Center of Inner Mongolia Autonomous region, Tongliao, China
  • 4 Key Laboratory of Zoonose Prevention and Control at Universities of Inner Mongolia Autonomous Region, Tongliao, China

The final, formatted version of the article will be published soon.

    mRNA vaccines utilize single-stranded linear DNA as a template for in vitro transcription. The mRNA is introduced into the cytoplasm via the corresponding delivery system to express the target protein, which then performs its relevant biological function. mRNA vaccines are beneficial in various fields, including cancer vaccines, infectious disease vaccines, protein replacement therapy, and treatment of rare diseases. They offer advantages such as a simple manufacturing process, a quick development cycle, and ease of industrialization. Additionally, mRNA vaccines afford flexibility in adjusting antigen designs and combining sequences of multiple variants, thereby addressing the issue of frequent mutations in pathogenic microorganisms. This paper aims to provide an extensive review of the global development and current research status of mRNA vaccines, with a focus on immunogenicity, classification, design, delivery vector development, stability, and biomedical application. Moreover, the study highlights current challenges and offers insights into future directions for development.a comprehensive review of immunogenicity, classification, design, delivery vector development, stability, biomedical application, challenges, and future developments of mRNA vaccines. It serves as a reference for research and development in fields such as infectious diseases, cancer, protein replacement therapy, and the treatment of rare diseases.

    Keywords: mRNA vaccines, Immunogenicity, Classification, Design, delivery vector development, stability, biomedical application

    Received: 07 Nov 2024; Accepted: 17 Feb 2025.

    Copyright: © 2025 Wei, Zhang, Wang, Xue, Dang and Zhai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Jingbo Zhai, School of Basic Medical Sciences, Inner Mongolia University for Nationalities, Tongliao, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more